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Abstract
Background/purpose Blood transfusionhas been considered as a risk factor for postoperative infection after major
surgery. However, the relationship between perioperative blood transfusion and the development of serious infec-
tions after pancreaticoduodenectomy remains controversial. The purpose of this study was to analyze risk factors
associated with postoperative serious infections following pancreaticoduodenectomy.
Methods We conducted a retrospective study of 212 patients who underwent pancreaticoduodenectomy during past
2 years and assessed the risk factors for serious infectious complications.
Results Serious infections developed in 61 patients (29 %) including 47 cases of surgical site infection (SSI), 19
cases of bacteremia, and 13 cases of pneumonia. One patient died of severe septic shock. A multivariate logistic
regression analysis of perioperative factors identified that pancreatic fistula (P\ 0.01, OR = 9.763) and blood
transfusion (P\ 0.01, OR = 3.216) were significant risk factors for serious infections. After excluding 46 patients
with pancreatic fistula, blood transfusion continued to be an independent risk factor for serious infections (P\ 0.01,
OR = 5.831).
Conclusion Blood transfusion was the strongest independent factor for serious infections after pancreaticoduo-
denectomy, which should be considered a quality indicator for the performance of pancreaticoduodenectomy.
Introduction
Postoperative mortality rates after pancreaticoduodenec-
tomy have substantially declined (\3 % in high volume
centers) in the past decade, with improvements in surgical
techniques and perioperative care [1]. However, the inci-
dence of postoperative complications such as infectious
complications continue to remain as high as approximately
50 % [2]. Serious infections such as surgical site infection
(SSI), bacteremia, and pneumonia often prolong hospital
stay increase medical expenses and occasionally cause
mortality [3]. Furthermore, blood transfusion had been
reported to be associated with infectious complications
after major surgery [4–7]. However, the relationship
between perioperative blood transfusion and the develop-
ment of serious infections after pancreaticoduodenectomy
remains undetermined. The purpose of this study was to
evaluate risk factors for serious infections after
pancreaticoduodenectomy.
Patients and methods
Data of 212 patients who underwent pancreaticoduo-
denectomy in the General Surgery Department of Peking
Union Medical College Hospital between January 2013 and
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December 2014 was collected. By chart review, perioper-
ative data including age, gender, body mass index (BMI),
nutritional screening scores (NRS-2002), clinical presen-
tation, preoperative laboratory findings and biliary drainage
procedures, type of resection, operative blood loss, red
blood cell transfusion, and histopathological findings were
recorded. For patients with obstructive jaundice, preoper-
ative biliary drainage was performed by percutaneous
transhepatic cholangiodrainage or endobiliary stent place-
ment through an endoscopic route. All patients received
prophylactic intravenous antibiotics (Ertapenem, 1.0 g)
30 min before skin incision. This regimen was continued
for 48–72 h postoperatively. A total of 212 patients
underwent pancreaticoduodenectomy alone or combined
with other organ resection. Reconstruction was conducted
by a modified Child method, and the pancreaticojejunos-
tomy was established by an end-to-side duct to mucosa
anastomosis with an external stenting tube inserted into the
pancreatic duct. Blood transfusion was indicated when Hb
levels of patients was lower than 10 g/L or HCT was lower
than 30 % during or 24 h after the operation. A pancreatic
fistula was defined as drain amylase level was[3 times the
upper limit of normal serum amylase level on postoperative
day three, according to the ISGPF2005 criteria [8].
Postoperative serious infectious complications include
(1) SSI including incisional and organ/apace SSI, (2) bac-
teremia, and (3) pneumonia. SSI was diagnosed according
to the modified definitions of surgical wound infection
provided by the Centers for Disease Control and Prevention
(CDC) National Nosocomial Infections Surveillance
(NNIS) system [9]. Bacteremia was defined as positive
blood cultures with high-grade fever (over 38.5 C).
Pneumonia was defined as a radiographic lung injury
associated with pulmonary infiltrate with positive sputum
cultures. When a serious infection was suspected, cultures
from the drainage fluid, wounds, blood, or sputum were
collected.
All statistical analysis was performed using SPSS 13.0
software. Continuous variables were expressed as
mean ± standard deviation, and means were compared
between groups using Student’s t test. Univariate analysis
was conducted using Pearson X2 test. A logistic regression
model for multivariate analysis was used to determine
independent risk factors. A P value B 0.05 was considered
statistically significant.
Results
Among the 212 patients who underwent pancreaticoduo-
denectomy, 78 (37 %) patients developed postoperative
infectious complications (Table 1). Among these 212
patients, 61 (29 %) patients developed serious infections
including 47 (22 %) patients with SSI, 19 (9 %) patients
with bacteremia, and 13 (6 %) patients with pneumonia.
Furthermore, one (0.5 %) patient died of multiple organ
failure due to aggressive septic shock.
Various perioperative factors were compared between
patients with and without serious infection (Table 2). The
difference in pancreatic fistula (P\ 0.01) and blood
transfusion (P\ 0.01) between the two groups was sta-
tistically significant. Multivariate logistic regression anal-
ysis results indicated that pancreatic fistula (P\ 0.01,
OR = 9.763) and blood transfusion (P = 0.003,
OR = 3.216) were independently correlated with serious
infections (Table 3).
Patients without pancreatic fistula were divided into two
groups according to the existence of serious infections.
Among the 33 patients with serious infections, 23 patients
had SSI, 15 patients had bacteremia, and 10 patients had
pneumonia (Table 4). A multivariate analysis of pre- and
intra-operative factors revealed that blood transfusion was
significantly associated with the development of serious
infections (P\ 0.01, OR = 5.831; Table 5). The most
frequently identified organisms in the study were Enter-
obacter species, followed by Enterococcus species.
Table 1 Patient characters and perioperative outcomes
Age 59 years (22–81)
Gender
Male F 128 (60 %)
Female 84 (40 %)
BMI 23.1 kg/m2 (15.6–31.0)
NRS-2002
\3 72 (34 %)
C3 140 (66 %)
DM 57 (26.9 %)
Disease
Malignant tumor 170 (80 %)
Benign tumor 42 (20 %)
Preoperative biliary drainage 75 (35 %)
Blood loss 711 ml (200–8000)
Pancreatic fistula 46 (22 %)
Serious infections 61 (29.0 %)
Intra-abdominal infection 45 (21.2 %)
Wound infection 7 (3.3 %)
Bacteremia 19 (9.0 %)
Pneumonia 13 (6.1 %)
Other infections 17 (8.0 %)
Cholangitis 16 (7.5 %)
Catheter infection 10 (4.7 %)
Mortality 1 (0.5 %)
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Discussions
Although pancreaticoduodenectomy has a century of his-
tory and has been commonly performed in large medical
centers, it remains as one of the complex abdominal
surgeries with high morbidity rates [10–12]. Furthermore,
the development of postoperative infectious complications
remains a significant problem. The present study revealed
that 37 % of patients had infectious complications, which
is similar to previous reports. The exact risk factors for
postoperative infection after pancreaticoduodenectomy
remain controversial. In addition, multiple factors such as
BMI ([25), poor nutrition, and operative time have been
reported to be related to postoperative infections in few
studies; among these factors, pancreatic fistula was repor-
ted as the most common independent risk factor associated
with the high incidence of infectious complications [13].
Table 2 Results of the univariate analysis of perioperative factors associated with serious infection
Variables No serious infection (n = 151) Serious infection (n = 61) P
Age (years) 58.4 ± 11.5 59.2 ± 11.2 0.68
Gender 0.38
Male (n = 128) 94 34
Female (n = 84) 57 27
BMI 22.7 ± 3.4 23.7 ± 3.7 0.06
NRS-2002 0.23
\3 (n = 72) 55 17
C3 (n = 140) 96 44
Diabetes mellitus 0.41
Yes (n = 57) 43 14
No (n = 155) 108 47
Hb (g/dl) 12.6 ± 1.9 12.1 ± 2.3 0.08
WBC (9103/mm3) 7.11 ± 2.8 7.89 ± 3.2 0.08
Lymphocytes (9103/mm3) 1.35 ± 0.6 1.35 ± 0.7 0.99
Albumin (g/dl) 3.8 ± 0.6 3.6 ± 0.6 0.045
Total bilirubin (mg/dl) 3.9 ± 4.5 5.3 ± 6.0 0.10
BUN (g/dl) 14.4 ± 5.2 13.2 ± 4.7 0.28
Preoperative biliary drainage 0.09
No (n = 137) 103 34
Percutaneous (n = 21) 11 10
Endoscopic (n = 54) 37 17
Pancreatic fistula 0.00
Yes (n = 46) 18 28
No (n = 166) 133 33
Blood loss (ml) 724 ± 680 681 ± 490 0.70
Red blood cell transfusion 0.003
Yes (n = 95) 58 37
No (n = 117) 93 24
Benign or malignant 0.12
Benign (n = 42) 34 8
Malignant (n = 170) 117 53
Extended resection 0.06
Yes (n = 29) 25 4
No (n = 183) 126 57
Table 3 Results of the multivariate analysis of risk factors associated
with serious infection
Variables B OR 95 % CI P
Pancreatic fistula 2.279 9.763 4.091–23.297 0.000
Transfusion 1.168 3.216 1.478–7.000 0.003
Combined resection -19.948 0 0 0.998
Constant -2.106 0.122
World J Surg (2016) 40:2507–2512 2509
123
Furthermore, our study revealed that the incidence of
serious infection in patients with pancreatic fistula (61 %)
was 39 higher than that in patients without pancreatic
fistula (20 %). Moreover, for patients without pancreatic
fistula, we found that 20 % of patients still developed
serious infections. A multivariate analysis of perioperative
factors revealed that blood transfusion was significantly
associated with the development of serious infections,
except for pancreatic fistula (P\ 0.01, OR = 5.831). For
pancreatic fistula, despite the advances in surgical tech-
niques, it continues to haunt pancreatic surgeons, because
none of the methods recommended for preventing pan-
creatic fistula have been conclusively proven to be effec-
tive. The reason for this is because its occurrence depends
on several factors, and pancreatic texture might be an
important factor [14] that could not be changed. Therefore,
this was not discussed in detail in this study.
Blood transfusion has been recognized as a significant
risk factor for minor and major complications in non-
pancreatic surgeries. Janssen et al. [15] reported that the
odds ratio for exposure to allogeneic blood transfusion in
patients undergoing lumbar spine surgery was 2.6 for any
postoperative infection. Xiao H et al. [16] also found that
Table 4 Results of the univariate analysis of pre- and intra-operative factors associated with serious infection
Variables No serious infection (n = 133) Serious infection (n = 33) P
Age (years) 58.7 ± 11.4 59.2 ± 12.5 0.84
Gender 0.25
Male (n = 128) 83 17
Female (n = 84) 50 16
BMI 22.7 ± 3.2 23.9 ± 3.7 0.05
NRS-2002 0.48
\3 (n = 72) 49 10
C3 (n = 140) 84 23
Diabetes mellitus 0.33
Yes (n = 57) 35 6
No (n = 155) 98 27
Hb (g/dl) 12.5 ± 1.9 12.6 ± 2.1 0.91
WBC (9103/mm3) 7.12 ± 2.8 7.88 ± 3.4 0.24
Lymphocytes (9103/mm3) 1.35 ± 0.6 1.44 ± 0.9 0.61
Albumin (g/dl) 3.8 ± 0.6 3.7 ± 0.6 0.57
Total bilirubin (mg/dl) 4.0 ± 5.3 5.5 ± 6.4 0.21
BUN (g/dl) 14.1 ± 6.5 13.8 ± 4.1 0.84
Preoperative biliary drainage 0.12
No (n = 137) 91 19
Percutaneous (n = 21) 9 6
Endoscopic (n = 54) 33 8
Blood loss (ml) 761 ± 802 650 ± 307 0.49
Red blood cell transfusion 0.00
Yes (n = 95) 53 25
No (n = 117) 80 8
Benign or malignant 0.31
Benign (n = 42) 31 5
Malignant (n = 170) 102 28
Combined resection 0.12
Yes (n = 29) 20 1
No (n = 183) 113 32
Table 5 Results of the multivariate analysis of pre- and intra-oper-
ative risk factors associated with serious infection
Variables B OR 95 % CI P
Transfusion 1.763 5.831 2.377–14.309 0.000
Combined resection -2.279 0.102 0.013–0.835 0.033
Constant -3.036 0.048
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perioperative blood transfusion was an independent risk
factor (OR = 2.71) for postoperative infectious complica-
tions after radical gastrectomy in patients with gastric
cancer. However, controversy remains on the impact of
blood transfusion on the outcomes of patients with pan-
creatic cancer. Ball et al. previously reported that transfu-
sion of red blood cells after pancreaticoduodenectomy is
linearly associated with 30-day morbidity [17]. However,
Sutton et al. found that blood transfusion was not associ-
ated with the increased rate of infectious complications
[18]. Therefore, we conducted this retrospective clinical
study to investigate risk factors related to serious infections
in an attempt to reduce postoperative infectious compli-
cations. Multiple factors including age, gender, body mass
index (BMI), nutritional screening scores (NRS-2002),
clinical presentation, preoperative laboratory findings and
biliary drainage procedures, type of resection, operative
blood loss, red blood cell transfusion, and histopathological
findings were analyzed in the 212 patients who underwent
pancreaticoduodenectomy and revealed that blood trans-
fusion was found to be an independent risk factor associ-
ated with postoperative infections. The results of this study
indicated that patients who received blood transfusion had
a 3.2 times higher risk of developing serious infections than
those without. Our study results also show that although
patients with serious infections almost had the same vol-
ume of blood loss as those without, a larger percentage of
patients (61.7 vs. 38.4 %) received blood transfusion in the
serious infection group than in the non-infection group.
Furthermore, considering the volume of blood transfused,
21.6 % of patients with serious infections had blood
transfusions of more than 2 units, while only 11.5 % of
patients without serious infections had more than 2 units of
blood transfusion.
Except for transfusion errors (i.e., receiving the wrong
blood) and transfusion-transmissible infections, increased
risk of infections after blood transfusion is thought to be a
result of transfusion-related immunosuppression [7, 19,
20]. Transfusions increase suppressor T cell activity and
inhibit natural killer cell activity [21, 22]. Furthermore, the
mitogenic activity of platelet-derived growth factors
increases during storage of blood and may stimulate tumor
growth following transfusion [23]. Therefore, perioperative
transfusion may stimulate tumor growth directly or by an
immunosuppressive effect, thereby having an adverse
effect on patient survival [24].
Although blood transfusion is necessary in complex
pancreatic procedures for severe blood loss, it has been
reported that a substantial portion of perioperative trans-
fusions among patients with PD did not meet predeter-
mined criteria [25]. Therefore, strict criteria should be
defined based on assessing the appropriateness of blood
transfusion and limiting perioperative transfusions should
be recommended. Choi reported pancreaticoduodenectomy
could be performed successfully without blood transfusion
in selected patients [26]. Our results also show that only
less than 50 % of patients in this study had perioperative
transfusion. Therefore, blood transfusions in pancreatic
surgery might be reduced by minimizing blood loss, pre-
operative blood donation, and reinfusion.
This study has limitations. First, it is a retrospective
study and selection bias could not be avoided. Second,
although there were clear guidelines on the criteria of
transfusion in our hospital, it may be influenced by indi-
vidual surgeon or anesthesiologist preference. Finally,
postoperative infections may be associated with the volume
of blood transfused, which was not taken into consideration
in the present study.
In conclusion, our study suggests that blood transfusion
was the strongest independent factor for serious infections
after pancreaticoduodenectomy, which should be consid-
ered a quality indicator for the performance of
pancreaticoduodenectomy.
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